QPRT
Nicotinate-nucleotide pyrophosphorylase [carboxylating]
Also known as: NADC_HUMAN, QPRTase
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15274
- Gene
- QPRT
- Ensembl
- ENSG00000103485
- Chromosome
- 16
- Canonical length
- 297 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a key enzyme in catabolism of quinolinate, an intermediate in the tryptophan-nicotinamide adenine dinucleotide pathway. Quinolinate acts as a most potent endogenous exitotoxin to neurons. Elevation of quinolinate levels in the brain has been linked to the pathogenesis of neurodegenerative disorders such as epilepsy, Alzheimer's disease, and Huntington's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
297 residues, UniProt reviewed canonical sequence.
>Q15274|QPRT
1 MDAEGLALLL PPVTLAALVD SWLREDCPGL NYAALVSGAG PSQAALWAKS PGVLAGQPFF
61 DAIFTQLNCQ VSWFLPEGSK LVPVARVAEV RGPAHCLLLG ERVALNTLAR CSGIASAAAA
121 AVEAARGAGW TGHVAGTRKT TPGFRLVEKY GLLVGGAASH RYDLGGLVMV KDNHVVAAGG
181 VEKAVRAARQ AADFTLKVEV ECSSLQEAVQ AAEAGADLVL LDNFKPEELH PTATVLKAQF
241 PSVAVEASGG ITLDNLPQFC GPHIDVISMG MLTQAAPALD FSLKLFAKEV APVPKIHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against QPRT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 221 nTPM
Expression across tissuesHPA
Tissue
- liver: 221 nTPM
- kidney: 111 nTPM
- adrenal gland: 103 nTPM
- epididymis: 90 nTPM
- duodenum: 58 nTPM
- cervix: 48 nTPM
Single-cell type
- cytotrophoblasts: 488 nCPM
- epididymal principal cells: 454 nCPM
- extravillous trophoblasts: 413 nCPM
- migrating cytotrophoblasts: 400 nCPM
- hepatocytes: 368 nCPM
- hofbauer cells: 234 nCPM
Immune cell
- non-classical monocyte: 9.1 nTPM
- myeloid DC: 5.9 nTPM
- intermediate monocyte: 5.3 nTPM
- classical monocyte: 4.3 nTPM
- plasmacytoid DC: 3.1 nTPM
- total PBMC: 1.9 nTPM
Brain region
- pons: 50 nTPM
- medulla oblongata: 41 nTPM
- midbrain: 38 nTPM
- cerebellum: 35 nTPM
- spinal cord: 31 nTPM
- white matter: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.12
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' NAD+ biosynthetic process from L-tryptophan
- NAD+ biosynthetic process
- quinolinate catabolic process
Molecular functions
- identical protein binding
- nicotinate-nucleotide diphosphorylase (carboxylating) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aldolase-type TIM barrel
- Nicotinate phosphoribosyltransferase-like, C-terminal
- Quinolinate phosphoribosyl transferase, C-terminal
- Nicotinate-nucleotide pyrophosphorylase
- Quinolinate phosphoribosyl transferase, N-terminal
- Nicotinate-nucleotide pyrophosphorylase/Putative pyrophosphorylase ModD
- Quinolinate phosphoribosyl transferase, N-terminal domain superfamily
- Quinolinate phosphoribosyl transferase, C-terminal domain
- Quinolinate phosphoribosyl transferase, N-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads QPRT as an antibody target. Whether an autoantibody or antibody against QPRT could matter depends on whether native QPRT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
QPRT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label QPRT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...